MREO Mereo BioPharma Group plc
Nasdaq · SEC CIK 1719714 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 64 since 2024-01-26, latest 2026-02-27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 27
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-16 | 2024-09-12+ | MREO | Scots-Knight Denise | CEO, Dir | S - Sale | $4.30 | -88.7K | 808.9K | -10% | -$381.3K |
| M | 2024-09-16 | 2024-09-12+ | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale | $4.30 | -148.1K | 190.8K | -44% | -$637.0K |
| M | 2024-09-16 | 2024-09-12+ | MREO | Sermon Charles | GC | S - Sale | $4.30 | -30.9K | 219.1K | -12% | -$133.0K |
| M | 2024-09-16 | 2024-09-12+ | MREO | Fox Christine Ann | CFO | S - Sale | $4.30 | -28.3K | 108.4K | -21% | -$121.6K |
| M | 2024-09-16 | 2024-09-12+ | MREO | Lewicki John A. | CSO | S - Sale | $4.30 | -16.1K | 89.6K | -15% | -$69.5K |
| D | 2024-09-13 | 2024-09-11 | MREO | Sermon Charles | GC | M - OptEx | $0.00 | +65.6K | 250.0K | +36% | $0 |
| DM | 2024-09-13 | 2024-09-11 | MREO | Hughes-Wilson Alexandra | See Remarks | M - OptEx | $0.9908 | +208.3K | 242.9K | +603% | +$206.4K |
| D | 2024-09-13 | 2024-09-11 | MREO | Lewicki John A. | CSO | M - OptEx | $0.00 | +46.0K | 94.8K | +94% | $0 |
| D | 2024-09-13 | 2024-09-11 | MREO | Scots-Knight Denise | CEO, Dir | M - OptEx | $0.00 | +188.1K | 897.6K | +27% | $0 |
| D | 2024-09-13 | 2024-09-11 | MREO | Fox Christine Ann | CFO | M - OptEx | $0.00 | +60.0K | 117.6K | +104% | $0 |
| DM | 2024-08-23 | 2024-08-22 | MREO | PAKIANATHAN DEEPIKA | Dir | M - OptEx | $1.44 | +105.2K | 1,825 | New | +$151.1K |
| D | 2024-08-23 | 2024-08-22 | MREO | PAKIANATHAN DEEPIKA | Dir | S - Sale+OE | $4.43 | -105.2K | 0 | -100% | -$466.2K |
| M | 2024-06-27 | 2024-06-25+ | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale | $3.48 | -33.1K | 57.5K | -37% | -$115.3K |
| M | 2024-06-27 | 2024-06-25+ | MREO | Lewicki John A. | CSO | S - Sale | $3.48 | -24.2K | 48.8K | -33% | -$84.3K |
| M | 2024-06-27 | 2024-06-25+ | MREO | Fox Christine Ann | CFO | S - Sale | $3.48 | -42.4K | 87.0K | -33% | -$147.7K |
| M | 2024-06-27 | 2024-06-25+ | MREO | Sermon Charles | GC | S - Sale | $3.48 | -46.4K | 216.6K | -18% | -$161.5K |
| M | 2024-06-27 | 2024-06-25+ | MREO | Scots-Knight Denise | CEO, Dir | S - Sale | $3.48 | -133.0K | 709.5K | -16% | -$463.0K |
| D | 2024-06-25 | 2024-06-21 | MREO | Fox Christine Ann | CFO | M - OptEx | $0.00 | +90.0K | 100.0K | +900% | $0 |
| D | 2024-06-25 | 2024-06-21 | MREO | Lewicki John A. | CSO | M - OptEx | $0.00 | +69.0K | 73.0K | +1,724% | $0 |
| D | 2024-06-25 | 2024-06-21 | MREO | Scots-Knight Denise | CEO, Dir | M - OptEx | $0.00 | +282.1K | 842.5K | +50% | $0 |
| D | 2024-06-25 | 2024-06-21 | MREO | Hughes-Wilson Alexandra | See Remarks | M - OptEx | $0.00 | +60.0K | 67.7K | +784% | $0 |
| D | 2024-06-25 | 2024-06-21 | MREO | Sermon Charles | GC | M - OptEx | $0.00 | +98.4K | 230.8K | +74% | $0 |
| 2024-06-17 | 2024-06-17 | MREO | WYZGA MICHAEL S | Dir | A - Grant | $3.99 | +25.1K | 25.1K | New | +$99.9K | |
| I | 2024-06-17 | 2024-06-17 | MREO | Bender Jeremy | Dir | A - Grant | $3.99 | +12.6K | 12.6K | New | +$50.1K |
| DM | 2024-05-23 | 2024-05-22 | MREO | Hughes-Wilson Alexandra | See Remarks | F - Tax | $1.26 | -67.9K | 7,650 | -90% | -$85.3K |
| DM | 2024-05-23 | 2024-05-22 | MREO | Hughes-Wilson Alexandra | See Remarks | M - OptEx | $1.23 | +168.3K | 82.7K | New | +$206.4K |
| DM | 2024-05-23 | 2024-05-22 | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale+OE | $2.97 | -100.4K | 32.6K | -76% | -$297.8K |
Purchase Sale Sale after option exercise All abbreviations